Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Primary myelodysplasia occurring in adults under 50 years old: a clinicopathologic study of 52 patients

Leukemia volume 16, pages 623–631 (2002)Cite this article

Abstract

Although myelodysplastic syndromes (MDSs) are generally thought to be diseases of elderly patients, younger patients also have rarely been diagnosed with MDS. This is a report of the clinical, morphologic and cytogenetic features of 52 cases of primary MDS occurring in adults under the age of 50 years. Cases secondary to chemotherapy or radiotherapy were excluded. There were 31 males and 21 females. The median age at presentation was 39 years (range, 18 to 49 years). The interval between onset of symptoms and diagnosis was brief (median, 4 weeks; range, 1–32 weeks). Of the 49 patients for whom information about duration of symptoms was available, 13 (27%) were asymptomatic. Forty-two (81%) of the patients were classified using FAB criteria for blood and bone marrow morphology: refractory anemia (RA), 11; refractory anemia with ringed sideroblasts (RARS), four; refractory anemia with excess blasts (RAEB), 12; chronic myelomonocytic leukemia (CMML), three; refractory anemia with excess blasts in transformation (RAEB-T), 12 patients. Ten patients could not be categorized. Abnormalities involving chromosome 7 was the most frequent cytogenetic abnormality (31%). Partial chromosomal deletion and chromosome gain were also common abnormalities (22% and 9%, respectively). Translocations accounted for only 9% of the main cytogenetic abnormalities encountered in this patient population. For the 49 patients for whom information regarding AML transformation was available, 23 (47%) progressed to acute myeloid leukemia, with an overall median time to progression of 2 months (range 3 weeks to 3 years). In each category except for RARS, approximately half of the patients progressed, with a slightly less median time to progression in RAEB-T than for the other subtypes of MDS. Thirteen patients underwent bone marrow transplantation at the time of presentation of their disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C . Proposals for the classification of the myelodysplastic syndromes Br J Haematol 1982 51: 189–199

    Article  CAS  PubMed  Google Scholar 

  2. Foucar K, Langdon RMI, Armitage JO, Olson DB, Carroll TJJ . Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases Cancer 1985 56: 553–561

    Article  CAS  PubMed  Google Scholar 

  3. LeBeau M, Albain K, Larson R, Vardiman J, Davis E, Blough R, Golomb H, Rowley J . Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes 5 and 7 J Clin Oncol 1986 4: 325–345

    Article  CAS  Google Scholar 

  4. Kantarjian HM, Keating MJ . Therapy-related leukemia and myelodysplastic syndrome Semin Oncol 1987 14: 435–443

    CAS  PubMed  Google Scholar 

  5. Pedersen-Bjergaard J . Therapy-related myelodysplasia and acute leukemia Leuk Lymphoma 1995 15: 11–12

    Article  PubMed  Google Scholar 

  6. Traweek ST, Slovak ML, Nademanee AP, Brynes RK, Niland JC, Forman SJ . Myelodysplasia and acute myeloid leukemia occurring after autologous bone marrow transplantation for lymphoma Leuk Lymphoma 1996 20: 365–372

    Article  CAS  PubMed  Google Scholar 

  7. Yakoub-Agha I, deLaSalmoniere P, Ribaud P, Sutton L, Wattel E, Kuentz M, Jouet J, Marit G, Milpied N, Deconinck E, Gratecos N, Leporrier M, Chabbert I, Caillot D, Damaj G, Dauriac C, Dreyfus F, Francois S, Molina L, Tanguy M, Chevret S, Gluckman E . Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients – report of the French Society of Bone Marrow Transplantation J Clin Oncol 2000 18: 963–971

    Article  CAS  PubMed  Google Scholar 

  8. Gyger M, Bonny Y, Forest L . Childhood monosomy 7 syndrome Am J Hematol 1982 13: 329–334

    Article  CAS  PubMed  Google Scholar 

  9. Passmore SJ, Hann IM, Stiller CA, Ramani P, Swansbury GJ, Gibbons B, Reeves BR, Chessells JM . Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system Blood 1995 85: 1742–1750

    CAS  PubMed  Google Scholar 

  10. Bader-Meunier B, Mielot F, Tchernia G, Buisine J, Delsol G, Duchayne E, Lemerle S, Leverger G, deLumley L, Manel A-M, Nathanson M, Plantaz D, Robert A, Schaison G, Sommelet D, Vilmer E . Myelodysplastic syndromes in childhood: report of 49 patients from a French multicentre study Br J Haematol 1996 92: 344–350

    Article  CAS  PubMed  Google Scholar 

  11. Passmore SJ, Hann IM . Paediatric myelodysplasia Br Med Bull 1996 52: 778–786

    Article  CAS  PubMed  Google Scholar 

  12. Creutzig U, Ritter J, Vormoor J, Ludwig WD, Niemeyer C, Reinisch I, Stollmann-Gibbels B, Zimmermann M, Harbott J . Myelodysplasia and acute myelogenous leukemia in Down's syndrome Leukemia 1996 10: 1677–1686

    CAS  PubMed  Google Scholar 

  13. Barnard D, Kalousek D, Wiersma S, Lange B, Benjamin D, Arthur D, Buckley J, Kobrinsky N, Neudorf S, Sanders J, Miller L, DeSwarte J, Shina D, Hammond G, Woods W . Morphologic, immunologic, and cytogenetic classification of acute myeloid leukemia and myelodysplastic syndrome in childhood: a report from the Children's Cancer Group Leukemia 1996 10: 5–12

    CAS  PubMed  Google Scholar 

  14. Davies SM, Wagner JE, Defor T, Blazar BR, Katsanis E, Kersey JH, Orchard PJ, McGlave PB, Weisdorf DJ, Ramsay NK . Unrelated donor bone marrow transplantation for children and adolescents with aplastic anaemia or myelodysplasia Br J Haematol 1997 96: 749–756

    Article  CAS  PubMed  Google Scholar 

  15. Groupe Francais de Cytogenetique Hematologique. Forty-four cases of childhood myelodysplasia with cytogenetics, documented by the Groupe Francais de Cytogenetique Hematologique Leukemia 1997 11: 1478–1485

  16. Fenaux P, Preudhomme C, Estienne M, Morel P, Lai J, Gardin C, Jouet J, Bauters F . De novo myelodysplastic syndromes in adult aged 50 or less. A report on 37 cases Leuk Res 1990 14: 1053–1059

    Article  CAS  PubMed  Google Scholar 

  17. Kerkhofs H, Hagemeijer A, Leeksma CHW, Abels J, denOttolander GJ, Somers R, Gerrits WBJ, Langenhuiÿen MMAC, von dem Borne AEGK, van Hemel JO, Geraedts JPM . The 5q− chromosome abnormality in haematological disorders: a collaborative study of 34 cases from the Netherlands Br J Haematol 1982 52: 365–381

    Article  CAS  PubMed  Google Scholar 

  18. Groupe Francaise De Morphologie Hematologique. French Registry of acute leukemia and myelodysplastic syndromes. Age distribution and hemogram analysis of the 4496 cases recorded during 1982–1983 and classified according to FAB criteria Cancer 1987 60: 1385–1394

  19. Goasguen J-E, Garand R, Bizet M, Bremond J-L, Gardais J, Callat MP, Accard F, Chaperon J . Prognostic factors of myelodysplastic syndromes – a simplified 3-D scoring system Leuk Res 1990 14: 255–262

    Article  CAS  PubMed  Google Scholar 

  20. Aul C, Gatterman N, Heyll A, Germing U, Derigs G, Schneider W . Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system Leukemia 1992 6: 52–59

    CAS  PubMed  Google Scholar 

  21. Mathew P, Tefferi A, Dewald GW, Goldberg SL, Su J, Hoagland HC, Noel P . The 5q− syndrome: a single-institution study of 43 consecutive patients Blood 1993 81: 1040–1045

    CAS  PubMed  Google Scholar 

  22. Sutton L, Chastang C, Ribaud P, Jouet J-P, Kuentz M, Attal M, Reiffers J, Tigaud J-M, Rio B, Dauriac C, Legros M, Dreyfus F, Lioure B, Troussard X, Milpied N, Witz F, Oriol P, Cahn J-Y, Michallet M, Gluckman E, Ifrah N, Pico J-L, Vilmer E, Leblond V . Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Blood 1996 88: 358–365

    CAS  PubMed  Google Scholar 

  23. Sole F, Espinet B, Sanz GF, Cervera J, Calasanz MJ, Luno E, Prieto F, Granada I, Hernandez JM, Cigudosa JC, Diez JL, Bureo E, Marques ML, Arranz E, Rios R, Martinez-Climent JA, Vallespi T, Florensa L, Woessner S . Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Espanol de Citogenetica Hematologica Br J Haematol 2000 108: 346–356

    Article  CAS  PubMed  Google Scholar 

  24. Mufti GJ, Stevens JR, Oscier DG, Hamblin TJ, Machin D . Myelodysplastic syndromes: a scoring system with prognostic significance Br J Haematol 1985 59: 425–433

    Article  CAS  PubMed  Google Scholar 

  25. Worsley A, Oscier DG, Stevens J, Darlow S, Figes A, Mufti GJ, Hamblin TJ . Prognostic features of chronic myelomonocytic leukemia: a modified Bournemouth score gives the best prediction of survival Br J Haematol 1988 68: 17–21

    Article  CAS  PubMed  Google Scholar 

  26. Sanz GF, Sanz MA, Vallespi T, Canizo MC, Torrabadella M, Garcia S, Irriguible D, San Miguel JF . Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients Blood 1989 74: 395–408

    CAS  PubMed  Google Scholar 

  27. Morel P, Hebbar M, Lai J-L, Duhamel A, Preudhomme C, Wattel E, Bauters F, Fenaux P . Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases Leukemia 1993 7: 1315–1323

    CAS  PubMed  Google Scholar 

  28. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J . International scoring system for evaluating prognosis in myelodysplastic syndromes Blood 1997 89: 2079–2088

    CAS  PubMed  Google Scholar 

  29. Nand S, Godwin JE . Hypoplastic myelodysplastic syndrome Cancer 1988 62: 958–964

    Article  CAS  PubMed  Google Scholar 

  30. Tuzuner N, Cox C, Rowe J, Watrous D, Bennett J . Hypocellular myelodysplastic syndromes (MDS): new proposals Br J Haematol 1995 91: 612–617

    Article  CAS  PubMed  Google Scholar 

  31. Mitelman F (ed). ISCN (1995): An International System for Human Cytogenetic Nomenclature Karger: Basel 1995

    Google Scholar 

  32. Brunning R . Proposed World Health Organization (WHO) classification of acute leukemia and myelodysplastic syndromes Mod Pathol 1999 12: 102

    Google Scholar 

  33. Karcher D, Frost A . The bone marrow in human immunodeficiency virus (HIV)-related disease. Morphology and clinical correlation Am J Clin Pathol 1991 95: 63–71

    Article  CAS  PubMed  Google Scholar 

  34. Watts E, Majer R, Green P, Mavor W . Hyperfibrotic myelodysplasia: a report of three cases showing haematological remission following treatment with prednisolone Br J Haematol 1991 78: 120–122

    Article  CAS  PubMed  Google Scholar 

  35. Mangi M, Mufti G . Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies Blood 1992 79: 198–205

    CAS  PubMed  Google Scholar 

  36. Clatch R, Krigman H, Peters M, Zutter M . Dysplastic haemopoiesis following orthotopic liver transplantation: comparison with similar changes in HIV infection and primary myelodysplasia Br J Haematol 1994 88: 685–692

    Article  CAS  PubMed  Google Scholar 

  37. Kaloutsi V, Kohlmeyer U, Maschek H, Nafe R, Choritz H, Amor A, Georgii A . Comparison of bone marrow and hematologic findings in patients with human immunodeficiency virus infection and those with myelodysplastic syndromes and infectious diseases Am J Clin Pathol 1994 101: 123–129

    Article  CAS  PubMed  Google Scholar 

  38. Hamblin TJ . Immunological abnormalities in myelodysplastic syndromes Semin Hematol 1996 33: 150–162

    CAS  PubMed  Google Scholar 

  39. Fenaux P, Morel P, Lai J . Cytogenetics of myelodysplastic syndromes Semin Hematol 1996 33: 127–138

    CAS  PubMed  Google Scholar 

  40. Brunning RD, McKenna RW . Tumors of the bone marrow In: Rosai J (ed.) Atlas of Tumor Pathology Armed Forces Institute of Pathology: Bethesda 1994 pp 161

    Google Scholar 

  41. Yunis JJ, Brunning RD . Prognostic significance of chromosomal abnormalities in acute leukaemias and myelodysplastic syndromes Clin Hematol 1986 15: 597–620

    CAS  Google Scholar 

  42. Boultwood J, Fidler C . Chromosomal deletions in myelodysplasia Leuk Lymphoma 1995 17: 71–78

    Article  CAS  PubMed  Google Scholar 

  43. Arber DA, Chang KL, Spielberger RT, Slovak ML . t(3;5) high-grade myelodysplasia and acute myeloid leukemia of young adults responds favorably to allogeneic bone marrow transplantation Leuk Res 1997 21: S52

    Article  Google Scholar 

  44. Grigg A, Gascoyne R, Phillips G, Horsman D . Clinical, haematological and cytogenetic features in 24 patients with structural rearrangements of the Q arm of chromosome 3 Br J Haematol 1993 83: 158–165

    Article  CAS  PubMed  Google Scholar 

  45. Escudier S, Albitar M, Robertson L, Andreeff M, Pierce S, Kantarjian H . Acute lymphoblastic leukemia following preleukemic syndromes in adultss Leukemia 1996 10: 473–477

    CAS  PubMed  Google Scholar 

  46. Lima CS, deSouza CA, Cardinalli IA, Lorand-Metze I . Lymphoblastic transformation of myelodysplastic syndrome Rev Paul Med 1997 115: 1508–1512

    CAS  Google Scholar 

  47. Balduini CL, Guarnone R, Pecci A, Centenara E, Invernizzi R, Ascari E . The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution Haematologica 1999 84: 12–16

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pathology, City of Hope National Medical Center, Duarte, CA, USA

    KL Chang, ML Slovak & DA Arber

  2. Division of Hematology/Bone Marrow Transplantation, City of Hope National Medical Center, Duarte, CA, USA

    MR O'Donnell & SJ Forman

  3. Division of Biostatistics, City of Hope National Medical Center, Duarte, CA, USA

    AC Dagis & JC Niland

Authors
  1. KL Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. MR O'Donnell
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. ML Slovak
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. AC Dagis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. DA Arber
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. JC Niland
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. SJ Forman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chang, K., O'Donnell, M., Slovak, M. et al. Primary myelodysplasia occurring in adults under 50 years old: a clinicopathologic study of 52 patients. Leukemia 16, 623–631 (2002). https://doi.org/10.1038/sj.leu.2402391

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402391

Keywords

This article is cited by

Search

Advanced search

Quick links